Prediction of Oral Absorption of Anionic Drugs that are Absorbed by the Monocarboxylic Acid Transport System

一元羧酸转运系统吸收的阴离子药物的口服吸收预测

基本信息

  • 批准号:
    11672216
  • 负责人:
  • 金额:
    $ 1.28万
  • 依托单位:
  • 依托单位国家:
    日本
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
  • 财政年份:
    1999
  • 资助国家:
    日本
  • 起止时间:
    1999 至 2000
  • 项目状态:
    已结题

项目摘要

Transcellular transport of carbenicillin (CBPC) and caridacillin (CIPC) through Caco-2 cell monolayer in the apical to basal direction was measured. CBPC is used pareterally because of poor absorption from the intestine, whereas CIPC is a prodrug of CBPC and is orally administered. Caco-2 cells were cultured on Transwell and the transport was measured at apical pH=6.0 and basal pH=7.4. Permeability of CIPC through Caco-2 cell monolayer was ca. 40-fold greater than that of CBPC, indicating that improved absorption of CIPC is due to much faster transport through the intestinal epithelial cells. Moreover, it was shown that CIPC, not CBPC, was transported by the monocarboxylic acid transport system that is located at the epithelial cells. It is probably true that modification of chemical structure from CBPC to CIPC resulted in much greater affinity to the transport system, which in turn resulted in greater absorption of the prodrug.Transport of cloxacillin (MCIPC), dicloxacillin (MDIPC), phenethicillin (PEPC), phenoxymethylpenicillin (PCV) and propicillin (PPPC) through Caco-2 cell monolayer was measured. Permeability of these drugs ranged from 0.8 to 1.0 x 10^<-6> cm/s. If we assume that these drugs are absorbed only by passive diffusion, extent of absorption after oral administration should be 10-20% of the dose (S.Chong et al., Pharm.Res.13 : 120-123, 1996). However, extent of oral absorption of these drugs in humans is 45-86%, which is much greater than that predicted assuming passive diffusion. The results suggest that a transport system, most probably the monocarboxylic acid transport system, is involved in the absorption of these drugs since these drugs have a carboxylic acid moiety and exist as mono-anion at physiological pH.Moreover, in our previous study, it was demonstrated that these drugs have affinity to the monocarboxylic acid transport system.
测定了卡比西林(carbenicillin, CBPC)和卡比西林(caridacillin, CIPC)在Caco-2细胞单分子膜上从尖向基的跨细胞转运。由于CBPC从肠道吸收较差,因此可以肠外使用,而CIPC是CBPC的前药,可以口服。在Transwell培养基上培养Caco-2细胞,在顶端pH=6.0、底部pH=7.4条件下测定Caco-2细胞的转运能力。CIPC通过Caco-2细胞单层的通透性约为CBPC的40倍,表明CIPC通过肠上皮细胞的运输速度更快,从而促进了CIPC的吸收。此外,研究表明,CIPC而不是CBPC是由位于上皮细胞的单羧酸运输系统运输的。从CBPC到CIPC的化学结构的修饰可能确实导致了对转运系统的更大亲和力,这反过来又导致了对前药的更大吸收。测定氯西林(MCIPC)、双氯西林(MDIPC)、苯乙西林(PEPC)、苯氧苄青霉素(PCV)和丙青霉素(PPPC)通过Caco-2细胞单层的转运情况。这些药物的渗透性范围为0.8 ~ 1.0 × 10^<-6> cm/s。如果我们假设这些药物仅通过被动扩散被吸收,口服给药后的吸收程度应为剂量的10-20% (s.b chong等人,药学研究中心)。13: 120-123, 1996)。然而,这些药物在人体的口服吸收程度为45-86%,这远远大于假设被动扩散的预测。结果表明,由于这些药物具有羧酸部分,并且在生理ph下以单阴离子形式存在,因此在这些药物的吸收过程中可能存在一个转运系统,最有可能是单羧酸转运系统。此外,在我们之前的研究中,已经证明这些药物与单羧酸转运系统具有亲和力。

项目成果

期刊论文数量(6)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Li YH, Ito K, Tsuda Y, Kohda R, Yamada H, Itoh T.: "Mechanism of intestinal absorption of of an orally active β-lactam prodrug : Uptake and transport of caridacillin in Caco-2 cells."J.Pharmacol.Exp.Ther.. 290. 958-964 (1999)
Li YH、Ito K、Tsuda Y、Kohda R、Yamada H、Itoh T.:“口服活性 β-内酰胺前药的肠道吸收机制:Caco-2 细胞中卡里西林的摄取和转运。”实验.. 290. 958-964 (1999)
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Li YH, Tanno M, Itoh T, Yamada H.: "Role of the monocarboxylic acid transport system in the intestinal absorption of an orally active β-lactam prodrug : Caridacillin as a model."Int.J.Pharmaceut. 191. 151-159 (1999)
Li YH、Tanno M、Itoh T、Yamada H.:“单羧酸转运系统在口服活性 β-内酰胺前药肠道吸收中的作用:Caridacillin 作为模型。”Int.J.Pharmaceut。191。151- 159 (1999)
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Itoh T, Ono K, Koido K, Li YH, Yamada H.: "Stereoselectivity of the folate transporter in rabbit small intestine : Studies with amethopterin enantiomers."Chirality. 13. 164-169 (2001)
Itoh T、Ono K、Koido K、Li YH、Yamada H.:“兔小肠叶酸转运蛋白的立体选择性:氨甲蝶呤对映体的研究。”手性。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
T.Itoh,K.Ono,K.Koido,Y-H.Li,H.Yamada: "Stereoselectivity of the folate transporter"Chirality. (in press). (2001)
T.Itoh,K.Ono,K.Koido,Y-H.Li,H.Yamada:“叶酸转运蛋白的立体选择性”手性。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
T.Itoh,K.Ono,K.Koido,Y-H.Li,H.Yamada: "Stereoselectivity of the folate transporter"Chirality. 13. 164-169 (2001)
T.Itoh,K.Ono,K.Koido,Y-H.Li,H.Yamada:“叶酸转运蛋白的立体选择性”手性。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

ITOH Tomoo其他文献

ITOH Tomoo的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('ITOH Tomoo', 18)}}的其他基金

Quantitative prediction of oral bioavailability independent of metabolic pathway
独立于代谢途径的口服生物利用度的定量预测
  • 批准号:
    17K08423
  • 财政年份:
    2017
  • 资助金额:
    $ 1.28万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Quantitative prediction of bioavailability and drug-drug interactions of orally administered drugs
口服药物生物利用度和药物相互作用的定量预测
  • 批准号:
    26460204
  • 财政年份:
    2014
  • 资助金额:
    $ 1.28万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Quantitative prediction of first pass metabolism and drug-drug interactions for orally administered drugs
口服药物首过代谢和药物相互作用的定量预测
  • 批准号:
    21590174
  • 财政年份:
    2009
  • 资助金额:
    $ 1.28万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Quantitative prediction of drug-drug interactions in the intestinal first pass metabolism
肠道首过代谢中药物相互作用的定量预测
  • 批准号:
    19590157
  • 财政年份:
    2007
  • 资助金额:
    $ 1.28万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Quantiative prediction of intestinal availability of CYP3A4 substrates
CYP3A4 底物肠道可用性的定量预测
  • 批准号:
    17590135
  • 财政年份:
    2005
  • 资助金额:
    $ 1.28万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Prediction of Oral Absorption of Anionic Drugs that are Absorbed by the Monocarboxylic Acid Transport System
一元羧酸转运系统吸收的阴离子药物的口服吸收预测
  • 批准号:
    14572097
  • 财政年份:
    2002
  • 资助金额:
    $ 1.28万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)

相似国自然基金

肺炎支原体外排泵ABC Transporter在大环内酯类耐药中的作用机制研究
  • 批准号:
    81672062
  • 批准年份:
    2016
  • 资助金额:
    25.0 万元
  • 项目类别:
    面上项目
一个可能与水稻花粉发育相关的ABC transporter 基因的功能验证与分析
  • 批准号:
    30970274
  • 批准年份:
    2009
  • 资助金额:
    30.0 万元
  • 项目类别:
    面上项目

相似海外基金

Role of intestinal serotonin transporter in post traumatic stress disorder
肠道血清素转运蛋白在创伤后应激障碍中的作用
  • 批准号:
    10590033
  • 财政年份:
    2024
  • 资助金额:
    $ 1.28万
  • 项目类别:
Anglia Ruskin University and Transporter Engineering Limited KTP 23_24 R1
安格利亚鲁斯金大学和运输工程有限公司 KTP 23_24 R1
  • 批准号:
    10070942
  • 财政年份:
    2024
  • 资助金额:
    $ 1.28万
  • 项目类别:
    Knowledge Transfer Partnership
Regulatory mechanism of ferroptosis via cystine/glutamate transporter regulated by food derived ingredients
食品衍生成分通过胱氨酸/谷氨酸转运蛋白调节铁死亡的调节机制
  • 批准号:
    23KK0109
  • 财政年份:
    2023
  • 资助金额:
    $ 1.28万
  • 项目类别:
    Fund for the Promotion of Joint International Research (International Collaborative Research)
Genetic and Functional Mechanisms in Citrate Transporter Disorder associated with SLC13A5
与 SLC13A5 相关的柠檬酸转运蛋白紊乱的遗传和功能机制
  • 批准号:
    10651203
  • 财政年份:
    2023
  • 资助金额:
    $ 1.28万
  • 项目类别:
PBPK Modeling & Simulation to Predict Transporter-Mediated Drug Secretion into Human Breast Milk
PBPK 建模
  • 批准号:
    10706040
  • 财政年份:
    2023
  • 资助金额:
    $ 1.28万
  • 项目类别:
Understanding of cholesterol transporter mechanisms via HS-AFM and computational modeling
通过 HS-AFM 和计算模型了解胆固醇转运机制
  • 批准号:
    22KF0153
  • 财政年份:
    2023
  • 资助金额:
    $ 1.28万
  • 项目类别:
    Grant-in-Aid for JSPS Fellows
Therapeutic efficacy of dapagliflozin, a selective inhibitor of sodium&#8211;glucose co-transporter type 2, for chronic heart failure in Japanese patients with type 2 diabetes mellitus
选择性钠抑制剂达格列净的治疗效果
  • 批准号:
    23K06224
  • 财政年份:
    2023
  • 资助金额:
    $ 1.28万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Elucidating the molecular mechanisms of dual function transporter/channels
阐明双功能转运蛋白/通道的分子机制
  • 批准号:
    FT220100717
  • 财政年份:
    2023
  • 资助金额:
    $ 1.28万
  • 项目类别:
    ARC Future Fellowships
Dual-function glutamate transporter/chloride channels in brain physiology and neurological diseases.
脑生理学和神经系统疾病中的双功能谷氨酸转运蛋白/氯离子通道。
  • 批准号:
    480399
  • 财政年份:
    2023
  • 资助金额:
    $ 1.28万
  • 项目类别:
    Operating Grants
Investigating the effect of lipid environment on ABC transporter structure and function
研究脂质环境对ABC转运蛋白结构和功能的影响
  • 批准号:
    2883785
  • 财政年份:
    2023
  • 资助金额:
    $ 1.28万
  • 项目类别:
    Studentship
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了